Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants
- PMID: 28880260
- PMCID: PMC5688018
- DOI: 10.1038/jp.2017.131
Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants
Abstract
Objective: To analyze reasons for low enrollment in a randomized controlled trial (RCT) of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late preterm newborns.
Study design: The original study was a multicenter RCT. Eligibility: ⩾34 weeks' gestation, <72 h old, mechanically ventilated, receiving inotrope. Primary outcome was NDI at 2 years; infants with diagnoses at high risk for NDI were excluded. This paper presents an analysis of reasons for low patient enrollment.
Results: Two hundred and fifty-seven of the 932 otherwise eligible infants received inotropes; however, 207 (81%) had exclusionary diagnoses. Only 12 infants were randomized over 10 months; therefore, the study was terminated. Contributing factors included few eligible infants after exclusions, open-label steroid therapy and a narrow enrollment window.
Conclusion: Despite an observational study to estimate the population, very few infants were enrolled. Successful RCTs of emergent therapy may require fewer exclusions, a short-term primary outcome, waiver of consent and/or other alternatives.
Conflict of interest statement
No authors report conflicts of interest for this study
References
-
- Fernandez E, Watterberg KL, Faix RG, Yoder BA, Walsh MC, Lacy CB, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Definitions of cardiovascular insufficiency and relation to outcomes in critically ill newborn infants. Am J Perinatol. 2015;32(11):1024–30. - PMC - PubMed
-
- Soliman AT, Taman KH, Rizk MM, Nasr IS, Alrimawy H, Hamido MS. Circulating adrenocorticotropic hormone (ACTH) and cortisol concentrations in normal, appropriate-for-gestational-age newborns versus those with sepsis and respiratory distress: Cortisol response to low-dose and standard-dose ACTH tests. Metabolism. 2004;53(2):209–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UG1 HD068263/HD/NICHD NIH HHS/United States
- U10 HD021385/HD/NICHD NIH HHS/United States
- U01 HD036790/HD/NICHD NIH HHS/United States
- U10 HD021364/HD/NICHD NIH HHS/United States
- UG1 HD068270/HD/NICHD NIH HHS/United States
- UG1 HD040689/HD/NICHD NIH HHS/United States
- UG1 HD053089/HD/NICHD NIH HHS/United States
- UG1 HD027856/HD/NICHD NIH HHS/United States
- UG1 HD034216/HD/NICHD NIH HHS/United States
- UG1 HD027880/HD/NICHD NIH HHS/United States
- U10 HD068284/HD/NICHD NIH HHS/United States
- UG1 HD027851/HD/NICHD NIH HHS/United States
- U10 HD034216/HD/NICHD NIH HHS/United States
- UG1 HD068278/HD/NICHD NIH HHS/United States
- U10 HD053089/HD/NICHD NIH HHS/United States
- U10 HD027856/HD/NICHD NIH HHS/United States
- U10 HD021373/HD/NICHD NIH HHS/United States
- U10 HD027880/HD/NICHD NIH HHS/United States
- UG1 HD027853/HD/NICHD NIH HHS/United States
- U10 HD053109/HD/NICHD NIH HHS/United States
- U10 HD040689/HD/NICHD NIH HHS/United States
- U10 HD040492/HD/NICHD NIH HHS/United States
- U10 HD068244/HD/NICHD NIH HHS/United States
- U10 HD068263/HD/NICHD NIH HHS/United States
- U10 HD068270/HD/NICHD NIH HHS/United States
- U10 HD027851/HD/NICHD NIH HHS/United States
- UG1 HD040492/HD/NICHD NIH HHS/United States
- UG1 HD021364/HD/NICHD NIH HHS/United States
- UG1 HD053109/HD/NICHD NIH HHS/United States
- U10 HD068278/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical